Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0F2RP
|
|||
| Former ID |
DIB006448
|
|||
| Drug Name |
VEGF/rGel
|
|||
| Synonyms |
VEGF/rGel (solid tumors/ocular diseases/bone metastases); VEGF/rGel (solid tumors/ocular diseases/bone metastases), Targa Therapeutics; VEGF121/rGel (solid tumors/ocular diseases/bone metastases), Targa Therapeutics; VEGF/rGel (solid tumors/age related macular degeneration/diabetic retinopathy/bone metastases), Targa Therapeutics; VEGF/rGel-Op (solid tumors/ocular diseases/bone metastases), Taga The
Click to Show/Hide
|
|||
| Indication | Diabetic retinopathy [ICD-11: 9B71.0; ICD-10: H36.0; ICD-9: 250.5] | Investigative | [1] | |
| Company |
Targa Therapeutics Corp
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.